d-apv has been researched along with (1rs,1's)-peaqx in 1 studies
| Studies (d-apv) | Trials (d-apv) | Recent Studies (post-2010) (d-apv) | Studies ((1rs,1's)-peaqx) | Trials ((1rs,1's)-peaqx) | Recent Studies (post-2010) ((1rs,1's)-peaqx) |
|---|---|---|---|---|---|
| 14 | 0 | 8 | 5 | 0 | 3 |
| Protein | Taxonomy | d-apv (IC50) | (1rs,1's)-peaqx (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.008 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.008 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.139 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.139 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.008 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.008 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, B; Jane, DE; Miller, JC; Monaghan, DT; Morley, RM; Tse, HW | 1 |
1 other study(ies) available for d-apv and (1rs,1's)-peaqx
| Article | Year |
|---|---|
Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists.
Topics: Animals; Animals, Newborn; Female; In Vitro Techniques; Male; Molecular Structure; Motor Neurons; Oocytes; Patch-Clamp Techniques; Piperazines; Protein Subunits; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Spinal Cord; Stereoisomerism; Xenopus laevis | 2005 |